1. Home
  2. MSD vs PROF Comparison

MSD vs PROF Comparison

Compare MSD & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSD
  • PROF
  • Stock Information
  • Founded
  • MSD 1993
  • PROF N/A
  • Country
  • MSD United States
  • PROF Canada
  • Employees
  • MSD N/A
  • PROF N/A
  • Industry
  • MSD Trusts Except Educational Religious and Charitable
  • PROF Medical/Dental Instruments
  • Sector
  • MSD Finance
  • PROF Health Care
  • Exchange
  • MSD Nasdaq
  • PROF Nasdaq
  • Market Cap
  • MSD 157.1M
  • PROF 186.3M
  • IPO Year
  • MSD N/A
  • PROF N/A
  • Fundamental
  • Price
  • MSD $7.67
  • PROF $7.52
  • Analyst Decision
  • MSD
  • PROF Strong Buy
  • Analyst Count
  • MSD 0
  • PROF 2
  • Target Price
  • MSD N/A
  • PROF $11.40
  • AVG Volume (30 Days)
  • MSD 70.2K
  • PROF 44.3K
  • Earning Date
  • MSD 01-01-0001
  • PROF 11-07-2024
  • Dividend Yield
  • MSD 11.26%
  • PROF N/A
  • EPS Growth
  • MSD N/A
  • PROF N/A
  • EPS
  • MSD N/A
  • PROF N/A
  • Revenue
  • MSD N/A
  • PROF $8,984,000.00
  • Revenue This Year
  • MSD N/A
  • PROF $56.11
  • Revenue Next Year
  • MSD N/A
  • PROF $171.96
  • P/E Ratio
  • MSD N/A
  • PROF N/A
  • Revenue Growth
  • MSD N/A
  • PROF 39.35
  • 52 Week Low
  • MSD $6.11
  • PROF $7.11
  • 52 Week High
  • MSD $7.46
  • PROF $11.42
  • Technical
  • Relative Strength Index (RSI)
  • MSD 49.09
  • PROF 43.53
  • Support Level
  • MSD $7.52
  • PROF $7.40
  • Resistance Level
  • MSD $7.65
  • PROF $8.22
  • Average True Range (ATR)
  • MSD 0.10
  • PROF 0.56
  • MACD
  • MSD 0.00
  • PROF -0.05
  • Stochastic Oscillator
  • MSD 49.50
  • PROF 6.62

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: